{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:38:55Z","timestamp":1754163535237,"version":"3.41.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Alzheimer\u2019s disease (AD) remains a global health and socioeconomic burden. Telemedicine has been more widely used since the beginning of the COVID-19 pandemic and may be an effective strategy to mitigate the rising costs associated with AD. This study aimed to assess technology readiness among older adults at risk of developing dementia, with the goal of informing the design and delivery of technology-based approaches in AD prevention research.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Cognitively unaffected older adults (<jats:italic>n<\/jats:italic>\u2009=\u2009226) from the CHARIOT PRO Substudy were invited to complete the CHARIOT Technology Questionnaire (CTQ). CTQ assessed technology experiences and attitudes, including \u2018technology readiness\u2019 via the Technology Readiness Index (TRI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Female participants scored, on average, lower TRI (M\u2009=\u200927.50, SD\u2009=\u20096.87) compared to males (M\u2009=\u200929.50, SD\u2009=\u20096.02). Furthermore, age predicted levels of technology readiness. Exploratory factor analysis determined two factors: \u201cTechnology Competence\u201d (Factor 1) and \u201cTechnology Trepidation\u201d (Factor 2). Gender differences were found for \u201cTechnology Competence\u201d (but not \u201cTechnology Trepidation\u201d), and age predicted \u201cTechnology Trepidation\u201d (but not \u201cTechnology Competence\u201d).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Differences in gender, age, \u201cTechnology Competence\u201d, and \u201cTechnology Trepidation\u201d may highlight those who need additional study and\/or support in remote-based AD dementia prevention trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>COVID-19 has accelerated our adoption of \u2018digitalisation\u2019 in AD dementia research. A deeper understanding of the barriers to technology readiness may help inform future AD research studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>The CHARIOT PRO SubStudy is registered with clinicaltrials.gov (NCT02114372).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12877-025-06158-3","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:11:50Z","timestamp":1753873910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Technology readiness among UK-based cognitively unaffected older adults during the COVID-19 pandemic: potential implications for decentralised alzheimer\u2019s disease prevention trials"],"prefix":"10.1186","volume":"25","author":[{"given":"S.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Udeh-Momoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kalsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kafetsouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"6158_CR1","unstructured":"World Health Organization (2023). Dementia. Retrieved from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"key":"6158_CR2","doi-asserted-by":"publisher","unstructured":"Wittenberg R, Hu B, Barraza-Araiza L, Rehill A. Projections of older people with dementia and costs of dementia care in the United Kingdom, 2019\u20132040. London. 2019;2019\u201311. https:\/\/doi.org\/10.1093\/ageing\/afz154, https:\/\/doi.org\/10.1002\/gps.5113.","DOI":"10.1093\/ageing\/afz154"},{"issue":"24","key":"6158_CR3","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules. 2020;25(24):5789. https:\/\/doi.org\/10.3390\/molecules25245789.","journal-title":"Molecules"},{"issue":"4","key":"6158_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust WJ, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine TJ, Phelps CH, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers & Dementia. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers & Dementia"},{"key":"6158_CR5","doi-asserted-by":"publisher","first-page":"104810","DOI":"10.1016\/j.nbd.2020.104810","volume":"139","author":"I Diouf","year":"2020","unstructured":"Diouf I, Bush AI, Ayton S, Alzheimer\u2019s disease Neuroimaging Initiative. Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying \u03b2-amyloid pathology. Neurobiol Dis. 2020;139:104810. https:\/\/doi.org\/10.1016\/j.nbd.2020.104810.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"6158_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimers Dement"},{"key":"6158_CR7","doi-asserted-by":"publisher","DOI":"10.2147\/dnnd.s228939","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen J, Langerman H. Alzheimer\u2019s disease\u2013 why we need early diagnosis. Degener Neurol Neuromuscul Dis. 2019. https:\/\/doi.org\/10.2147\/dnnd.s228939.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"6158_CR8","unstructured":"Alzheimer\u2019s Research UK. (2020). Cost of dementia for hospitals in England doubles in a decade. Retrieved from: https:\/\/www.alzheimersresearchuk.org\/cost-of-dementia-hospitals-england-doubles\/"},{"issue":"5","key":"6158_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1192\/bjb.2019.18","volume":"43","author":"LD Cook","year":"2019","unstructured":"Cook LD, Nichol KE, Isaacs JD. The London memory service audit and quality improvement programme. BJPsych Bull. 2019;43(5):215\u201320. https:\/\/doi.org\/10.1192\/bjb.2019.18.","journal-title":"BJPsych Bull"},{"issue":"3","key":"6158_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/0971721820912894","volume":"25","author":"M Quet","year":"2020","unstructured":"Quet M, Dahdah MA. Technologies without borders? The digitization of society in a postcolonial world. Sci Technol Soc. 2020;25(3):363\u20137. https:\/\/doi.org\/10.1177\/0971721820912894.","journal-title":"Sci Technol Soc"},{"issue":"11","key":"6158_CR11","doi-asserted-by":"publisher","first-page":"e22287","DOI":"10.2196\/22287","volume":"22","author":"SGS Shah","year":"2020","unstructured":"Shah SGS, Nogueras D, Van Woerden H, Kiparoglou V. The COVID-19 pandemic: a pandemic of lockdown loneliness and the role of digital technology. J Med Internet Res. 2020;22(11):e22287. https:\/\/doi.org\/10.2196\/22287.","journal-title":"J Med Internet Res"},{"key":"6158_CR12","unstructured":"World Health Organization. (2019). \u201cWHO guideline recommendations on digital interventions for health system strengthening\u201d. Retrieved from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/311941\/9789241550505-eng.pdf?ua=1"},{"key":"6158_CR13","unstructured":"BBC. (2020). Coronavirus: Strict new curbs on life in UK announced by PM (2020, 24th March 2020). Retrieved from: https:\/\/www.bbc.co.uk\/news\/uk-52012432"},{"issue":"5","key":"6158_CR14","doi-asserted-by":"publisher","first-page":"e9434","DOI":"10.2196\/19434","volume":"22","author":"J Goodman-Casanova","year":"2020","unstructured":"Goodman-Casanova J, Dura-Perez E, Guzman-Parra J, Cuesta-Vargas A, Mayoral-Cleries F. Telehealth home support during COVID-19 confinement for community-dwelling older adults with mild cognitive impairment or mild dementia: survey study. J Med Internet Res. 2020;22(5):e9434. https:\/\/doi.org\/10.2196\/19434.","journal-title":"J Med Internet Res"},{"key":"6158_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000202956","author":"R Yaari","year":"2023","unstructured":"Yaari R, Holdridge K, Ferguson M, Wessels A, Sims J. Decentralized approaches in TRAILBLAZER-ALZ 3 (P7\u20136.006). Neurology. 2023. https:\/\/doi.org\/10.1212\/wnl.0000000000202956.","journal-title":"Neurology"},{"issue":"5","key":"6158_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/arclin\/acx050","volume":"32","author":"JB Miller","year":"2017","unstructured":"Miller JB, Barr W. The technology crisis in neuropsychology. Arch Clin Neuropsychol. 2017;32(5):541\u201354. https:\/\/doi.org\/10.1093\/arclin\/acx050.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"6158_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/adr-170007","volume":"1","author":"TC Castanho","year":"2017","unstructured":"Castanho TC, Sousa N, Santos NC. When new technology is an answer for old problems: the use of videoconferencing in cognitive aging assessment. J Alzheimers Dis Rep. 2017;1(1):15\u201321. https:\/\/doi.org\/10.3233\/adr-170007.","journal-title":"J Alzheimers Dis Rep"},{"issue":"8","key":"6158_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/arclin\/acx140","volume":"33","author":"H Wadsworth","year":"2018","unstructured":"Wadsworth H, Dhima K, Womack K, Hart J, Weiner M, Hynan LS, Cullum CM. Validity of teleneuropsychological assessment in older patients with cognitive disorders. Arch Clin Neuropsychol. 2018;33(8):1040\u20135. https:\/\/doi.org\/10.1093\/arclin\/acx140.","journal-title":"Arch Clin Neuropsychol"},{"key":"6158_CR19","doi-asserted-by":"publisher","unstructured":"Tate A, Su\u00e1rez-Calvet M, Ekelund M, Eriksson S, Eriksdotter M, Van Der Flier WM, Georges J, Kivipelto M, Kramberger MG, Lindgren P, Gispert JD, L\u00f6tj\u00f6nen J, Persson S, Pla S, Solomon A, Thurfjell L, Wimo A, Winblad B, et al. Precision medicine in neurodegeneration: the IHI-PROMINENT project. Front Neurol. 2023;14. https:\/\/doi.org\/10.3389\/fneur.2023.1175922.","DOI":"10.3389\/fneur.2023.1175922"},{"issue":"7","key":"6158_CR20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1080\/0144929x.2021.1882577","volume":"41","author":"J Mariano","year":"2021","unstructured":"Mariano J, Marques S, Ramos MR, Gerardo F, Da Cunha CL, Girenko A, Alexandersson J, Stree B, Lamanna M, Lorenzatto M, Mikkelsen LP, Bundg\u00e5rd-J\u00f8rgensen U, R\u00eago S, De Vries H. Too old for technology? Stereotype threat and technology use by older adults. Behav Inf Technol. 2021;41(7):1503\u201314. https:\/\/doi.org\/10.1080\/0144929x.2021.1882577.","journal-title":"Behav Inf Technol"},{"key":"6158_CR21","doi-asserted-by":"publisher","unstructured":"Udeh-Momoh C, De Jager-Loots CA, Price G, Middleton L. (2020). Transition from physical to virtual visit format for a longitudinal brain aging study, in response to the Covid\u201019 pandemic. Operationalizing adaptive methods and challenges. Alzheimers Dement\u00a06(1). https:\/\/doi.org\/10.1002\/trc2.12055","DOI":"10.1002\/trc2.12055"},{"issue":"1","key":"6158_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1094670514539730","volume":"18","author":"A Parasuraman","year":"2014","unstructured":"Parasuraman A, Colby CL. An updated and streamlined technology readiness index. J Serv Res. 2014;18(1):59\u201374. https:\/\/doi.org\/10.1177\/1094670514539730.","journal-title":"J Serv Res"},{"key":"6158_CR23","unstructured":"Jamovi. The Jamovi Project [Software]. 2024. https:\/\/www.jamovi.org."},{"issue":"jul05 3","key":"6158_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4633","volume":"345","author":"M Limb","year":"2012","unstructured":"Limb M. NHS boards see telehealth only as a means of saving money, warns expert. BMJ. 2012;345(jul05 3): e4633. https:\/\/doi.org\/10.1136\/bmj.e4633.","journal-title":"BMJ"},{"issue":"7","key":"6158_CR25","doi-asserted-by":"publisher","first-page":"e24917","DOI":"10.2196\/24917","volume":"23","author":"S Winward","year":"2021","unstructured":"Winward S, Patel T, Al-Saffar M, Noble MJ. The effect of 24\/7, digital-first, NHS primary care on acute hospital spending: retrospective observational analysis. J Med Internet Res. 2021;23(7):e24917. https:\/\/doi.org\/10.2196\/24917.","journal-title":"J Med Internet Res"},{"key":"6158_CR26","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","volume":"78","author":"D Zhu","year":"2021","unstructured":"Zhu D, Montagne A, Zhao Z. Alzheimer\u2019s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci. 2021;78:4907\u201320. https:\/\/doi.org\/10.1007\/s00018-021-03830-w.","journal-title":"Cell Mol Life Sci"},{"key":"6158_CR27","doi-asserted-by":"publisher","unstructured":"Ali SA, Arif TB, Maab H, Baloch M, Manazir S, Jawed F, Ochani RK. Global interest in telehealth during COVID-19 pandemic: an analysis of Google Trends\u2122. Cureus. 2020;12(9). https:\/\/doi.org\/10.7759\/cureus.10487.","DOI":"10.7759\/cureus.10487"},{"issue":"4","key":"6158_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.pop.2022.04.002","volume":"49","author":"J Shaver","year":"2022","unstructured":"Shaver J. The state of telehealth before and after the COVID-19 pandemic. Prim Care. 2022;49(4):517\u201330. https:\/\/doi.org\/10.1016\/j.pop.2022.04.002.","journal-title":"Prim Care"},{"issue":"8","key":"6158_CR29","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1016\/s2589-7500(21)00118-7","volume":"3","author":"CA Figueroa","year":"2021","unstructured":"Figueroa CA, Luo T, Aguilera A, Lyles CR. The need for feminist intersectionality in digital health. Lancet Digit Health. 2021;3(8):e526\u201333. https:\/\/doi.org\/10.1016\/s2589-7500(21)00118-7.","journal-title":"Lancet Digit Health"},{"issue":"18","key":"6158_CR30","doi-asserted-by":"publisher","first-page":"9556","DOI":"10.3390\/ijerph18189556","volume":"18","author":"K Dopelt","year":"2021","unstructured":"Dopelt K, Avni N, Haimov-Sadikov Y, Golan I, Davidovitch N. Telemedicine and eHealth literacy in the era of COVID-19: a cross-sectional study in a peripheral clinic in Israel. Int J Environ Res Public Health. 2021;18(18):9556. https:\/\/doi.org\/10.3390\/ijerph18189556.","journal-title":"Int J Environ Res Public Health"},{"key":"6158_CR31","doi-asserted-by":"publisher","first-page":"233372142199374","DOI":"10.1177\/2333721421993747","volume":"7","author":"J Ranieri","year":"2021","unstructured":"Ranieri J, Guerra F, Angione AL, Di Giacomo D, Passafiume D. Cognitive reserve and digital confidence among older adults as new paradigm for resilient aging. Gerontol Geriatr Med. 2021;7:233372142199374. https:\/\/doi.org\/10.1177\/2333721421993747.","journal-title":"Gerontol Geriatr Med"},{"issue":"3","key":"6158_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/s1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448\u201360. https:\/\/doi.org\/10.1017\/s1355617702813248.","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"6158_CR33","doi-asserted-by":"publisher","first-page":"e1002251","DOI":"10.1371\/journal.pmed.1002251","volume":"14","author":"HX Wang","year":"2017","unstructured":"Wang HX, MacDonald SW, Dekhtyar S, Fratiglioni L. Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: a community-based cohort study. PLoS Med. 2017;14(3):e1002251. https:\/\/doi.org\/10.1371\/journal.pmed.1002251.","journal-title":"PLoS Med"},{"key":"6158_CR34","doi-asserted-by":"publisher","first-page":"102620","DOI":"10.1016\/j.nicl.2021.102620","volume":"30","author":"S Subramaniapillai","year":"2021","unstructured":"Subramaniapillai S, Rajagopal S, Snytte J, Otto AR, Einstein G, Rajah MN. Sex differences in brain aging among adults with family history of Alzheimer\u2019s disease and APOE4 genetic risk. Neuroimage Clin. 2021;30:102620. https:\/\/doi.org\/10.1016\/j.nicl.2021.102620.","journal-title":"Neuroimage Clin"},{"issue":"S7","key":"6158_CR35","doi-asserted-by":"publisher","first-page":"e064397","DOI":"10.1002\/alz.064397","volume":"18","author":"CK Chooi","year":"2022","unstructured":"Chooi CK, Gavett BE, Weinborn M, Rainey-Smith SR. Sex differences in the protective effects of cognitive reserve. Alzheimers Dement. 2022;18(S7):e064397. https:\/\/doi.org\/10.1002\/alz.064397.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"6158_CR36","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1016\/S2468-2667(23)00214-","volume":"8","author":"Y Chen","year":"2023","unstructured":"Chen Y, Bandosz P, Stoye G, Liu Y, Wu Y, Lobanov-Rostoysky S, French E, Kivimaki M, Livingston G, Liao J, Brunner EJ. Dementia Incidence Trend in England and Wales 2002\u20132019 and Projection for Dementia Burden to 2040: analysis of data from the English Longitudinal Study of Ageing. Lancet Public Health. 2023;8(11):e859\u201367. https:\/\/doi.org\/10.1016\/S2468-2667(23)00214-.","journal-title":"Lancet Public Health"},{"key":"6158_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.874025","author":"M Gomez-Hernandez","year":"2022","unstructured":"Gomez-Hernandez M, Adrian SW, Ferr\u00e9 X, Villalba-Mora E. Implicit, explicit, and structural barriers and facilitators for information and communication technology access in older adults. Front Psychol. 2022. https:\/\/doi.org\/10.3389\/fpsyg.2022.874025.","journal-title":"Front Psychol"},{"issue":"15","key":"6158_CR38","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/healthcare11152146","volume":"11","author":"O Cho","year":"2023","unstructured":"Cho O, Cho J. Changed digital technology perceptions and influencing factors among older adults during the COVID-19 pandemic. Healthcare. 2023;11(15):2146. https:\/\/doi.org\/10.3390\/healthcare11152146.","journal-title":"Healthcare"},{"issue":"3","key":"6158_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/geront\/gnw249","volume":"58","author":"SJ Czaja","year":"2017","unstructured":"Czaja SJ, Boot WR, Charness N, Rogers WA, Sharit J. Improving social support for older adults through technology: findings from the PRISM randomized controlled trial. Gerontologist. 2017;58(3):467\u201377. https:\/\/doi.org\/10.1093\/geront\/gnw249.","journal-title":"Gerontologist"},{"key":"6158_CR40","unstructured":"Hutchings, R. (2020). The impact of Covid-19 on the use of digital technology in the NHS. Nuffield Trust, Retrieved from: https:\/\/www.nuffieldtrust.org.uk\/sites\/default\/files\/2020-08\/the-impact-of-covid-19-on-the-use-of-digital-technology-in-the-nhs-web-2.pdf"},{"key":"6158_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/alz.077098","author":"P Giannakopoulou","year":"2023","unstructured":"Giannakopoulou P, Majeed A, Solomon A, Middleton L, Kivipelto M. E-FINGERPRINT pilot study: assessing the feasibility of digital data collection and multidomain lifestyle guidance towards the prevention of cognitive decline and dementia. Alzheimers Dement. 2023. https:\/\/doi.org\/10.1002\/alz.077098.","journal-title":"Alzheimers Dement"},{"key":"6158_CR42","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.65","author":"H Feldman","year":"2023","unstructured":"Feldman H, Belleville S, Nygaard HB, Montero-Odasso M, Durant J, Lupo J, Revta C, Chan SK, Cuesta M, Slack P, Winer S, Brewster P, Hofer SM, Lim AG, Centen A, Jacobs DM, Anderson N, Walker J, Speechley M, Feldman HH, Lupo JL, Chan S, Slack PJ, Brewster PWH, Lim A, Anderson ND, Walker JD, Speechley MR, Zou GY, Chertkow H. Protocol for the brain health support program study of the Canadian therapeutic platform trial for multidomain interventions to prevent dementia (CAN-THUMBS UP): a prospective 12-month intervention study. J Prev Alzheimers Dis. 2023. https:\/\/doi.org\/10.14283\/jpad.2023.65.","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"6158_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12737","volume":"19","author":"JB Langbaum","year":"2022","unstructured":"Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry MC, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Irizarry M, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS. Recommendations to address key recruitment challenges of Alzheimer\u2019s disease clinical trials. Alzheimers Dement. 2022;19(2):696\u2013707. https:\/\/doi.org\/10.1002\/alz.12737.","journal-title":"Alzheimers Dement"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06158-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:03:06Z","timestamp":1753945386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06158-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6158"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06158-3","relation":{},"ISSN":["1471-2318"],"issn-type":[{"type":"electronic","value":"1471-2318"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the course of our study, we introduced an additional questionnaire to gather further insights related to \u201ctechnology readiness\u201d. The questionnaire was provided only to participants who were already active in the CHARIOT PRO Substudy. Informed consent was obtained from all participants within the CHARIOT PRO Substudy. Participation in the questionnaire was entirely voluntary, and respondents were informed that their involvement would not affect their continued participation in the CHARIOT PRO Substudy. All responses were collected and handled in accordance with the confidentiality and ethical standards established for the CHARIOT PRO Substudy.To ensure the quality and integrity of research, the CHARIOT PRO Substudy is conducted in accordance with GCP Guidelines, GPPs issued by ISPE, applicable national guidelines, and to the Declaration of Helsinki 2013, as modified by the 52nd World Medical Assembly (WMA), Edinburgh, Scotland, 2000, and clarified by the WMA General Assembly, Washington 2002 and Tokyo 2004. The study has received approval from the National Research Ethics Service (NRES) Committee London Central (reference 15\/LO\/0711 [IRAS 140764]), as well as independent ethics review by committees from the local sites.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L.M. reports grants from Johnson and Johnson, Merck, Takeda, Gates Ventures, Eisai, NIHR, UKRI, and research funding from the Davos Alzheimer\u2019s Collaborative (DAC), outside the submitted work, all to Imperial College London. C.U. declares the following funding received through grants or awards, with payments made to their institution: MRC UKRI Applied Global Health Award (2024), National Institutes of Health (2024), Wellcome Leap Dynamic Resilience Grant (2023), Alzheimer\u2019s Association Sex and Gender Differences Award (2023), Davos Alzheimer\u2019s Collaborative Global Cohort Fund (2023), Global Brain Health Institute Project Award (2023), and UK Defence and Security Accelerator Veterans\u2019 Health Innovation Fund (2022). All other authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"563"}}